1. Home
  2. HFWA vs RCUS Comparison

HFWA vs RCUS Comparison

Compare HFWA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HFWA
  • RCUS
  • Stock Information
  • Founded
  • HFWA 1927
  • RCUS 2015
  • Country
  • HFWA United States
  • RCUS United States
  • Employees
  • HFWA N/A
  • RCUS N/A
  • Industry
  • HFWA Banks
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HFWA Finance
  • RCUS Health Care
  • Exchange
  • HFWA Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • HFWA 847.9M
  • RCUS 906.4M
  • IPO Year
  • HFWA N/A
  • RCUS 2018
  • Fundamental
  • Price
  • HFWA $22.13
  • RCUS $9.17
  • Analyst Decision
  • HFWA Hold
  • RCUS Buy
  • Analyst Count
  • HFWA 3
  • RCUS 8
  • Target Price
  • HFWA $27.67
  • RCUS $20.86
  • AVG Volume (30 Days)
  • HFWA 156.5K
  • RCUS 741.4K
  • Earning Date
  • HFWA 07-24-2025
  • RCUS 08-06-2025
  • Dividend Yield
  • HFWA 4.34%
  • RCUS N/A
  • EPS Growth
  • HFWA 13.61
  • RCUS N/A
  • EPS
  • HFWA 1.43
  • RCUS N/A
  • Revenue
  • HFWA $221,312,000.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • HFWA $21.88
  • RCUS N/A
  • Revenue Next Year
  • HFWA $8.67
  • RCUS $28.73
  • P/E Ratio
  • HFWA $15.47
  • RCUS N/A
  • Revenue Growth
  • HFWA 3.23
  • RCUS N/A
  • 52 Week Low
  • HFWA $19.84
  • RCUS $6.50
  • 52 Week High
  • HFWA $27.58
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • HFWA 30.20
  • RCUS 48.59
  • Support Level
  • HFWA $22.51
  • RCUS $9.14
  • Resistance Level
  • HFWA $23.82
  • RCUS $9.93
  • Average True Range (ATR)
  • HFWA 0.69
  • RCUS 0.48
  • MACD
  • HFWA -0.36
  • RCUS -0.04
  • Stochastic Oscillator
  • HFWA 6.98
  • RCUS 21.48

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: